Han C - Search Results

1

Identification of immune-related gene signature for non-small cell lung cancer patients with immune checkpoint inhibitors.

Wang L, Han C, Cai C, Wu J, Chen J, Su C. Wang L, et al. Among authors: han c. Heliyon. 2024 Feb 27;10(5):e26974. doi: 10.1016/j.heliyon.2024.e26974. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38463866 Free PMC article.

2

Treatment of small cell lung cancer: recent advances.

Chu X, Han C, Su C. Chu X, et al. Among authors: han c. Curr Opin Oncol. 2022 Jan 1;34(1):83-88. doi: 10.1097/CCO.0000000000000804. Curr Opin Oncol. 2022. PMID: 34698669 Review.

3

Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy.

Yu X, Li J, Ye L, Zhao J, Xie M, Zhou J, Shen Y, Zhou F, Wu Y, Han C, Qian J, Chu T, Su C. Yu X, et al. Among authors: han c. Transl Lung Cancer Res. 2021 Sep;10(9):3782-3792. doi: 10.21037/tlcr-21-681. Transl Lung Cancer Res. 2021. PMID: 34733628 Free PMC article.

4

Favorable clinical outcomes of checkpoint inhibitor-based combinations after progression with immunotherapy in advanced non-small cell lung cancer.

Yu X, Chu X, Wu Y, Zhou J, Zhao J, Zhou F, Han C, Su C. Yu X, et al. Among authors: han c. Cancer Drug Resist. 2021 May 24;4(3):728-739. doi: 10.20517/cdr.2021.28. eCollection 2021. Cancer Drug Resist. 2021. PMID: 35582303 Free PMC article.

5

Immunotherapy resistance of lung cancer.

Yu X, Han C, Su C. Yu X, et al. Among authors: han c. Cancer Drug Resist. 2022 Feb 8;5(1):114-128. doi: 10.20517/cdr.2021.101. eCollection 2022. Cancer Drug Resist. 2022. PMID: 35582531 Free PMC article.

6

Treatment efficacy of HER2-mutant lung adenocarcinoma by immune checkpoint inhibitors: a multicenter retrospective study.

Chu X, Qiang H, Xie M, Li X, Zhao J, Wu Y, Zhou J, Ye J, Zhao C, Han C, Chu T, Su C. Chu X, et al. Among authors: han c. Cancer Immunol Immunother. 2022 Jul;71(7):1625-1631. doi: 10.1007/s00262-021-03100-5. Epub 2021 Nov 7. Cancer Immunol Immunother. 2022. PMID: 34743223 Free PMC article.

7

Immunohistochemistry and clinical value of sirtuin 2 in non-metastasized non-small cell lung cancer.

Gao CX, Chen B, Xie HK, Han CN, Luo J. Gao CX, et al. J Thorac Dis. 2019 Sep;11(9):3973-3979. doi: 10.21037/jtd.2019.08.102. J Thorac Dis. 2019. PMID: 31656671 Free PMC article.

8

SPOP promotes FADD degradation and inhibits NF-κB activity in non-small cell lung cancer.

Luo J, Chen B, Gao CX, Xie HK, Han CN, Zhou CC. Luo J, et al. Biochem Biophys Res Commun. 2018 Sep 26;504(1):289-294. doi: 10.1016/j.bbrc.2018.08.176. Epub 2018 Sep 4. Biochem Biophys Res Commun. 2018. PMID: 30190126

9

Programmable DNA Circuit-Facilitated Determination of Circulating Extracellular Vesicle PD-L1 for Lung Cancer Diagnosis and Immunotherapy Response Prediction.

Bo B, Li W, Li J, Han C, Fang Q, Yang M, Ni J, Zhou C. Bo B, et al. Among authors: han c. ACS Appl Mater Interfaces. 2023 Apr 12;15(14):17696-17704. doi: 10.1021/acsami.3c01607. Epub 2023 Mar 28. ACS Appl Mater Interfaces. 2023. PMID: 36978260

10

Deep learning for colorectal cancer detection in contrast-enhanced CT without bowel preparation: a retrospective, multicentre study.

Yao L, Li S, Tao Q, Mao Y, Dong J, Lu C, Han C, Qiu B, Huang Y, Huang X, Liang Y, Lin H, Guo Y, Liang Y, Chen Y, Lin J, Chen E, Jia Y, Chen Z, Zheng B, Ling T, Liu S, Tong T, Cao W, Zhang R, Chen X, Liu Z. Yao L, et al. Among authors: han c. EBioMedicine. 2024 Jun 6;104:105183. doi: 10.1016/j.ebiom.2024.105183. Online ahead of print. EBioMedicine. 2024. PMID: 38848616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,411 results

Search Page